Key result
Ideal Life's Essential 8 metrics linked to ~58% lower CV mortality in renal insufficiency.
Why the study?
The benefits of ideal cardiovascular-health metrics in patients with renal insufficiency remained unclear.
Does adherence to Life's Essential 8 ideal cardiovascular health metrics reduce cardiovascular mortality in patients with renal insufficiency?
Cohort (n=29,682)
Yes
Does adherence to Life's Essential 8 ideal cardiovascular health metrics reduce cardiovascular mortality in patients with renal insufficiency?
Effect estimate: HR 0.42 (95% CI 0.25-0.70)
Adherence to Life's Essential 8 cardiovascular health metrics is associated with significantly reduced cardiovascular and all-cause mortality in patients with renal insufficiency.
May support CVH promotion in renal insufficiency; leaves open causal confirmation by RCTs.
BACKGROUND: The benefits of ideal cardiovascular-health metrics (ICVHMs) in patients with renal insufficiency remain unclear. This study aimed to investigate the associations between ICVHM and prognosis in a renal insufficiency population. METHODS: The trial enrolled 29,682 participants from the US National Health and Nutrition Examination Survey (NHANES), 2007-2018, with mortality follow-up through December 31, 2019. Participants were divided into three groups based on estimated glomerular filtration rates. Cardiovascular health was assessed using new "Life's Essential 8" metrics. Cox regression analyses based on NHANES data were used to determine the associations between ICVHMs and cardiovascular mortality in patients with renal insufficiency. RESULTS: During a mean follow-up of 6.58 years, ideal cardiovascular health (hazard ratio [HR] = 0.42; 95% confidence interval [CI]; 0.25-0.70) and ideal health behavior (HR = 0.53; 95% CI; 0.39-0.73) reduced cardiovascular mortality in participants with renal insufficiency. For each one ICVHM increment, a 25% reduction in cardiovascular mortality was recorded (95% CI; 0.69-0.82). When compared with participants with normal renal function, for those with mild renal insufficiency, the HR for cardiovascular mortality gradually decreased from 1.47 (95% CI; 0.85-2.52) in those who had ≤1 ICVHMs to 0.30 (95% CI; 0.12-0.77) in participants who had >6 ICVHMs. CONCLUSIONS: From an ICVHM perspective, enhanced cardiovascular benefits were observed in individuals with renal insufficiency, coupled with a reduced risk of all-cause mortality. Furthermore, when compared with individuals with normal renal function, increased ICVHMs can mitigate adverse risks associated with renal impairment.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted a cohort in Renal insufficiency (n=29,682). Ideal cardiovascular-health metrics (Life's Essential 8) vs. Lower number of ideal cardiovascular-health metrics was evaluated on Cardiovascular mortality (HR 0.42, 95% CI 0.25-0.70). Ideal cardiovascular health based on Life's Essential 8 metrics reduced cardiovascular mortality in participants with renal insufficiency (HR 0.42; 95% CI 0.25-0.70).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: